Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

Medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

New drug ‘Lecanemab’ slows the effects of Alzheimer’s disease

After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.
Amyloid

Amyloid Research Consultants

Amyloid Research Consultants enable research targeting root causes of diseases such as Alzheimer’s, Parkinson’s, and diabetes.
Brain disease diagnosis with medical doctor seeing Magnetic Resonance Imaging MRI film diagnosing elderly ageing patient neurodegenerative illness problem for neurological medical treatment

Machine learning is helping us understand Alzheimer’s disease

Using machine learning to pinpoint the most accurate means and timelines for anticipating the advancement of Alzheimer’s disease.
beer texture in a glass

Could beer hops give insight into treating Alzheimer’s?

Beer hops have been found to provide unique health benefits for Alzheimer’s disease, preventing the clumping of amyloid beta proteins.
brain scan image

COVID-19 causes brain inflammation similar to Parkinson’s disease

COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
alzheimers, brain scan

The expansion of potential Alzheimer’s drugs

Alzheimers drugs have been shown able to target insulin receptors located in cerebral microvessels, massively expanding the future of drug production and testing

Unlocking life-changing dementia treatments

Is better diagnosis the key to unlocking life-changing dementia treatments? Dr Susan Mitchell, Head of Policy at Alzheimer’s Research UK provides the answer.
The epidemiology of Alzheimer’s - MRI brian of Dementia patient

PAVE: Global research study on epidemiology of Alzheimer’s disease

To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
Older women leaning over table and writing a letter as a leisure activity

Reduce risk of dementia through leisure activities

Dementia poses a risk to us all, but research shows that there are leisure activities that are scientifically proven to reduce risk of dementia.
ArrestAD

ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease

The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.
Alzheimer’s, mild cognitive impairment

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s

Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.

A Bluetooth tracking device to aid the search for older people with dementia who...

Getting lost can affect caregivers and families of older people with dementia – now, a Bluetooth tracking device can assist the search for their loved ones.
preclinical alzheimer's disease, novel marker

Searching for a novel marker of preclinical Alzheimer’s disease

Research suggests that multisensory integration could be used as a novel marker for preclinical Alzheimer’s disease given reported associations between magnitude of visual-somatosensory integration and important cognitive and motor outcomes.
breakthroughs in dementia research

What we need to make breakthroughs in dementia research

David Thomas, Head of Policy (Access and Innovation) at Alzheimer’s Research UK, looks at what we need to make breakthroughs in dementia research.
brain disease

Three rare brain diseases that attack your language skills

According to NorthWestern Medicine, there are three different brain diseases that attack the language areas in the left hemisphere of the brain.
late-onset alcohol abuse

Late-onset alcohol abuse can be symptom of dementia

According to new results in the Journal of Alzheimer’s Disease, patients who start abusing alcohol in later life – after age 40 – maybe doing so due to underlying dementia
dementia day care, dementia day care

The importance of dementia day care services during COVID-19

Professor Timothy Kwok, Director of the Jockey Club Centre for Positive Ageing, and Research Manager Ms Bel Wong, explain the necessity of dementia day care services during the pandemic.
amyloid, membrane channels structures

Amyloid oligomer & membrane channel structures

H. Robert Guy, CEO from Amyloid Research Consultants, ascertains why amyloid oligomer & membrane channels structures can & must be determined.
indigenous communities dementia, Tsimane and moseten

Lowest global rates of dementia in Indigenous communities

The healthier pre-industrial lifestyles which Indigenous communities live by present solutions in preventing Alzheimer’s and dementia ­– as seen in their lower rates of the disease.
dementia covid-19, alzheimer's

How to help someone living with dementia understand the COVID-19 pandemic

Kym Ward, Dementia Project Coordinator at The Brain Charity, offers insight into how to support those living with dementia during times of uncertainty and isolation.

Follow Open Access Government